Skip to main content
Beat Cancer EU Website Logo
IGHG Guideline on Hypothalamic-Pituitary Dysfunction
Quality of LifeAllGuidelines

IGHG Guideline on Hypothalamic-Pituitary Dysfunction

Recommendations for surveillance for hypothalamic-pituitary dysfunction in survivors

Year:2021

Childhood, adolescent and young adult cancer survivors may develop treatment-induced hypothalamic-pituitary dysfunction. Because of this risk, at-risk survivors may benefit from surveillance of hypothalamic-pituitary dysfunction surveillance. This guideline describes the groups at risk and the surveillance recommended for this group

Discussion & Questions

Note: Comments are for discussion and clarification only. For medical advice, please consult with a healthcare professional.

Leave a Comment

Minimum 10 characters, maximum 2000 characters

No comments yet

Be the first to share your thoughts!

Related Resources

Palliative Care vs Hospice: The Real Difference (And Why It Matters Now, Not Later)

Palliative Care vs Hospice: The Real Difference (And Why It Matters Now, Not Later)

If your oncologist mentioned "palliative care" or "hospice" and your stomach dropped, take a breath. The two words get u...

Quality of LifeAll
Read
Travel Insurance for Cancer Patients: What You Need to Know Before You Go

Travel Insurance for Cancer Patients: What You Need to Know Before You Go

Travel insurance for cancer patients feels impossible at first — quotes come back sky-high, online forms reject you, som...

UpdatedPolicyAll
Read
When the Oncologist Says No More Chemo: What It Means and What Comes Next

When the Oncologist Says No More Chemo: What It Means and What Comes Next

When your oncologist says "no more chemo," the room can go quiet in a way you weren't ready for. You're not sure if you...

Long-term Follow-up CareAll
Read